Revolo Biotherapeutics is a privately held, venture-funded biotechnology firm engaged in the development of unique and revolutionary therapies. Looking to learn more? Don’t hesitate to contact us.
There are no upcoming events at this time.
February 27th 2023 – 2023 American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Oral Presentation – IRL201104, A Novel Immunomodulatory Peptide, Shows A Long Lasting Reduction In Anaphylaxis Symptoms And Allergy Biomarkers In A Murine Model Of Food Allergy – San Antonio
January 9th 2023 – LifeSci Partners Corporate Access Event
Corporate presentation – San Francisco
November 17th 2022 – Tides Europe 2022
Presentation – Resetting the Immune System without Shutting it Down – Vienna & Virtual